BioMarin Pharmaceuticals BMRN United States — Total long-lived assets

Other geography segments

Similar metrics at other companies

SMMTUnited States — Long-Lived Assets

$7.58M+30.7%

TRMBUnited States — Total long-lived assets

$178.9M+0.5%

ALGNU.S. — Total long-lived assets

$480.7M+137%

ALGNUnited States — Total long-lived assets

$178.77M+8.5%

PODDUnited States — Long-Lived Assets

$453.2M+1.8%

RVTYUNITED STATES — Total net long-lived assets

$341.17M-2.2%

Questions, answered.

What is BioMarin Pharmaceuticals's united states — total long-lived assets?

BioMarin Pharmaceuticals (BMRN) reported united states — total long-lived assets of $639.67M in Q4 2025.

How has BioMarin Pharmaceuticals's united states — total long-lived assets changed year-over-year?

BioMarin Pharmaceuticals's united states — total long-lived assets decreased by 15.3% year-over-year, from $755.07M to $639.67M.

What does united states — total long-lived assets mean?

The total value of long-term physical and intangible assets held by the company within the United States.

How do you interpret united states — total long-lived assets?

An increase suggests significant capital expenditure or acquisition of assets to support domestic growth, while a decrease may indicate asset depreciation, divestiture, or a shift in capital allocation strategy away from domestic infrastructure.

How does united states — total long-lived assets compare across companies?

Peers in the pharmaceutical industry typically report this as part of geographic segment disclosures, allowing for comparison of asset intensity and regional investment footprints.